Calcium Phosphate Nanoparticles Functionalized with a Cardio-Specific Peptide

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cardiovascular Research

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of death, necessitating innovative therapeutic approaches.
• Peptide-based therapies offer promise for CVDs but face challenges with stability and targeted delivery.
• Nanoparticle-based drug delivery systems are crucial for enhancing peptide stability and efficacy.

Purpose of the Study:

• To develop and characterize calcium phosphate nanoparticles (CaP NPs) for delivering a cardio-specific mimetic peptide (MP).
• To evaluate the biocompatibility and therapeutic potential of MP-loaded CaP NPs in cardiac cells.

Main Methods:

• Two distinct wet precipitation syntheses were employed to load MP onto CaP NPs, with one utilizing sodium polyacrylate as a templating agent.
• Characterization of CaP NPs involved assessing crystallinity, size, surface charge, and morphology.
• In vitro studies were conducted using HL-1 cardiomyocytes to evaluate biocompatibility and restoration of intracellular calcium flux.

Main Results:

• MP-loaded CaP NPs exhibited tunable physicochemical properties based on synthesis parameters.
• The developed CaP NPs demonstrated excellent biocompatibility with HL-1 cardiomyocytes.
• MP-loaded CaP NPs successfully restored intracellular calcium flux in stressed cardiac cells, indicating therapeutic efficacy.

Conclusions:

• Calcium phosphate nanoparticles represent a viable nanomaterial for delivering mimetic peptides in cardiovascular disease treatment.
• The developed CaP NP formulations show significant potential for optimizing peptide-based therapies for CVDs.
• This study provides a foundation for further development of nanoparticle-based strategies for cardiovascular therapeutics.